Tenon Medical (TNONW) Liabilities and Shareholders Equity (2021 - 2026)

Tenon Medical has reported Liabilities and Shareholders Equity for 6 years, with the latest figure at $12.8 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 4.15% year-over-year to $12.8 million; the trailing twelve-month figure through Mar 2026 stood at $45.1 million (up 6.61% YoY), and the FY2025 full-year result was $10.8 million, up 9.32% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $12.8 million, up from $10.8 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $18.1 million in Q2 2022, with the low at $6.0 million in Q2 2024.
• Average Liabilities and Shareholders Equity over 5 years is $10.5 million, with a median of $10.4 million recorded in 2025.
• Year-over-year, Liabilities and Shareholders Equity plunged 51.01% in 2023 and jumped 85.05% in 2025.
• Tracing TNONW's Liabilities and Shareholders Equity over 5 years: stood at $11.1 million in 2022, then slumped by 42.78% to $6.3 million in 2023, then surged by 55.13% to $9.8 million in 2024, then grew by 9.32% to $10.8 million in 2025, then rose by 19.31% to $12.8 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $12.8 million (Q1 2026), $10.8 million (Q4 2025), and $10.4 million (Q3 2025), per Business Quant data.

Peer Comparison